Xvivo Perfusion AB (publ) (XVIPY)
OTCMKTS · Delayed Price · Currency is USD
4.670
-1.330 (-22.17%)
Sep 18, 2025, 1:00 PM EDT
Xvivo Perfusion AB Employees
Xvivo Perfusion AB had 190 employees as of December 31, 2024. The number of employees increased by 30 or 18.75% compared to the previous year.
Employees
190
Change (1Y)
30
Growth (1Y)
18.75%
Revenue / Employee
$448,386
Profits / Employee
$60,686
Market Cap
608.56M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 190 | 30 | 18.75% |
| Dec 31, 2023 | 160 | 20 | 14.29% |
| Dec 31, 2022 | 140 | 27 | 23.89% |
| Dec 31, 2021 | 113 | 31 | 37.80% |
| Dec 31, 2020 | 82 | 42 | 105.00% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tian'an Technology Group | 8 |
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
Xvivo Perfusion AB News
- 2 months ago - Xvivo Perfusion AB (XVIPF) Q2 2025 Earnings Call Highlights: Navigating Challenges and Seizing ... - GuruFocus
- 2 months ago - Q2 2025 Xvivo Perfusion AB Earnings Call Transcript - GuruFocus